Camilla Jandus

Lausanne Branch
Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

Programmed cell death-1: from a T-cell immune checkpoint to a regulator of Natural Killer cell biology.

Programmed cell death-1: from a T-cell immune checkpoint to a regulator of Natural Killer cell biology.

Journal: Frontiers in cell and developmental biology

Published: June 30, 2026

Addendum: Neural anticipation of virtual infection triggers an immune response.

Addendum: Neural anticipation of virtual infection triggers an immune response.

Journal: Nature neuroscience

Published: April 24, 2026

Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer.

Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer.

Journal: Science advances

Published: June 27, 2025

Selective activation of interleukin-2/interleukin-15 receptor signaling in tumor microenvironment using paired bispecific antibodies.

Selective activation of interleukin-2/interleukin-15 receptor signaling in tumor microenvironment using paired bispecific antibodies.

Journal: Journal for immunotherapy of cancer

Published: March 06, 2025

PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade.

PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 13, 2024

Robust estimation of cancer and immune cell-type proportions from bulk tumor ATAC-Seq data.

Robust estimation of cancer and immune cell-type proportions from bulk tumor ATAC-Seq data.

Journal: eLife

Published: October 09, 2024

UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunity.

UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunity.

Journal: Cell reports. Medicine

Published: September 23, 2024

STAT1 and STAT4 expression as prognostic biomarkers in patients with bladder cancer.

STAT1 and STAT4 expression as prognostic biomarkers in patients with bladder cancer.

Journal: Molecular and clinical oncology

Published: August 16, 2024

The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer.

The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer.

Journal: Cancer treatment reviews

Published: August 13, 2024

Circulating innate lymphoid cells are dysregulated in patients with prostate cancer.

Circulating innate lymphoid cells are dysregulated in patients with prostate cancer.

Journal: Cellular & molecular biology letters

Published: August 09, 2024

Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor.

Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor.

Journal: Journal of leukocyte biology

Published: May 31, 2024

Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.

Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.

Journal: Cancer immunology research

Published: February 28, 2024

Showing 1-12 of 90

Last Updated: 09/26/2026